This award recognises an outstanding early to mid-career individual or team who has made an inspirational contribution to the biosciences and to industry–academia interactions.
The Industry and Academic Collaboration Award is presented annually to an outstanding individual or team who has made an inspirational contribution to the biosciences and to industry–academia interactions. This award aims to recognize the achievements of early to mid-career scientists from anywhere in the world.
The recipient is given:
- A grant to attend a relevant event or training course
- A trophy
- The opportunity to present a lecture at a Society event or webinar
- An invitation to submit an article to one of our journals, with any fees waived
- Awarded to an outstanding individual or team who has made an inspirational contribution to the biosciences and to industry–academia interactions
- Nominees are typically mid-career, within 10-20 years of receiving their highest qualification
- Nominees must demonstrate commitment to build, support, and nurture future talent
- Open to nominees based in the UK or internationally
- This award is open to individuals and teams
The Awards Committee will consider the following aspects of all nominations for the Industry and Academic Collaboration Award as appropriate:
- Scope and scale of collaboration
- Originality of scientific contribution
- Achievements and impact
- Quality of outputs – publications and/or patents and/or software
- Industry-academic interactions
- Commitment to build, support, and nurture future talent e.g., mentorship
- Other indicators of esteem demonstrated by the nominator
Nominations for the 2024 Awards have now closed.
The Biochemical Society Awards programme is presented annually. Find out how to nominate in a future round.How to Nominate
For further information please get in touch with the Awards department.
Related content5 items
International AwardThe International Award is presented annually and recognises outstanding and independent research that illustrates the importance of the molecular biosciences in the advancement of life sciences research.
The GlaxoSmithKline AwardThe GlaxoSmithKline Award is given in recognition of research leading to new advances in medical science and is made in respect of research carried out in the UK or the Republic of Ireland during the 7 years preceding the date of nomination.
The AstraZeneca AwardGenerously supported by AstraZeneca, this award is made every 3 years in recognition of outstanding work which, through biomedical advances, leads to the development of a new reagent or method. The research should have been carried out in a UK or Republic of Ireland laboratory.
The Keilin Memorial LectureThe Keilin Memorial Lecture was first awarded in 1964 to commemorate the late David Keilin. The lecturer and subject of the lecture are selected, by the Awards Committee, from a field related to the interests of Keilin in bioenergetics, electron transfer, and mitochondrial biology.
The 2023 Industry & Academic Collaboration Award will be presented to Dr Jacob Bush. Jacob is a Director in the Chemical Biology department at GSK. After completing a degree in chemistry from the University of Oxford, Jake studied for a DPhil in chemical biology in the lab of Chris Schofield. With an interest for translational science, he joined GSK in 2015 to explore ways to accelerate drug discovery. By combining chemoproteomic and chemogenomic approaches using reactive fragments, Jake and his team aim to discover new targets with therapeutic potential and use machine learning algorithms to accelerate the drug discovery process.
Jacob said: “I am delighted to receive this award as it recognises cutting edge work by a team of outstanding scientists both at GSK and at our academic partner institutions. It is a privilege to work with a diverse and energised team to build chemical biology approaches that have the potential to transform biomedical research and accelerate the discovery medicines for patients.”
The 2022 Industry and Academic Collaboration Award was presented to Professor Matthias Trost. Professor Trost is a proteomics expert with over 20 years of experience in mass spectrometry. He studied chemistry in Freiburg, Germany, and Manchester, UK, completing his PhD in Cellular Microbiology and Proteomics at the Helmholtz-Centre for Infection Research in Braunschweig, Germany and his postdoctoral research at the Institute for Research in Immunology and Cancer in Montréal, Canada. In 2010, he became Group Leader and Head of Proteomics at the MRC Protein Phosphorylation and Ubiquitylation Unit (MRC PPU) at the University of Dundee. In 2016, he was appointed Professor of Proteomics at Newcastle University. Since 2019, he has been a Wellcome Trust Investigator. Matthias’ main biological interest is in phagosome and macrophage biology and particularly signalling events in innate immunity driven by phosphorylation and ubiquitylation. In recent years, his lab has additionally focused on clinical proteomics and using mass spectrometry for drug discovery. For this, the lab pioneered the usage of high-throughput MALDI TOF mass spectrometry for drug screening which has attracted significant industry interest.
Matthias said: “I am very happy to have received this award which recognises the fruitful industrial collaborations we have had over the years and is credit to the fantastic students and postdocs in my lab. The award will further promote our translational work using mass spectrometry in the area of drug discovery."
The 2021 Industry and Academic Collaboration Award was presented to Dr Pamela Williams at Astex Pharmaceuticals, Cambridge, UK. She has a DPhil in Molecular Biophysics from Oxford University and is a Senior Director in the Molecular Sciences Group at Astex Pharmaceuticals. Pamela’s current focus is on the integration of cryoEM structure determination into the drug discovery process, building upon her interest in structure-based drug discovery technologies. Before joining Astex Pharmaceuticals, she was a postdoctoral research associate at the Scripps Research Institute, La Jolla, where her work focused on the X-ray structure determination of metalloenzymes involved in electron transfer and xenobiotic metabolism.
On winning the Industry and Academic Collaboration Award, Pamela said: “The recognition of industrial scientists at all levels and stages of their careers is a positive message. I’m delighted that this award rightly highlights the significant impact collaborations between academic and industrial groups can have on pushing forward the frontiers of science.”
The 2020 Industry and Academic Collaboration Award was presented to Professor Matthew Dalby of University of Glasgow, UK.
Matthew obtained his PhD at Queen Mary, University of London on osteoblast response to bioactive composites. After becoming interested in the effects of topography on cell function, he moved to Glasgow in 2000 to work for Adam Curtis, Chris Wilkinson and Mathis Riehle. He secured a BBSRC David Phillips Fellowship to explore mesenchymal stem cell response to nanotopography. In 2014 he became Professor of Cell Engineering at the University of Glasgow and diversified his research to include understanding of cells with protein nanonetworks / ultra-low dose growth factor delivery which recently resulted in a first veterinary trial in a dog where a large bone defect in the front leg was fully regenerated and is now functional and load-bearing. With collaborators, Matthew has developed a nanovibrational bioreactor, the Nanokick, that can be used to drive three dimensional bone formation with no need for material or chemical inducement. More recently, he led a successful bid for an EPSRC-SFI Centre for Doctoral Training where a lot of industrial support was achieved. The CDT aims to build a community of interdisciplinary scientists to develop UK standing in development of humanised 3D tissues to reduce animal experimentation in drug discovery. Matthew has been elected as a Fellow of the Royal Society of Edinburgh.
Matthew said: “I was very surprised, but clearly delighted to receive news of winning this award. Over the last few years much of my effort has focused on engaging UK industry to form a community to support development of PhD students into diverse careers. This award makes all this effort feel very worthwhile.”
Matthew presented his Award lecture on Thursday 4 June 2020 during the ‘ELRIG-Biochemical Society webinar: Cellular Therapy’.
The 2019 Industry and Academic Collaboration Award was awarded to Maddy Parsons from King’s College London, UK. Maddy’s research is focused on using a range of live-cell advanced imaging approaches to enable precise spatio-temporal dissection of receptor and cytoskeletal signalling. A key focus of this research is in the development and implementation of novel microscopy approaches and FRET-based biosensors to study cell adhesion and migration signalling in 2D and 3D environments. Maddy has established collaborations with clinicians to uncover novel molecular mechanisms underpinning diseases such as skin blistering, cancer, wound healing and inflammation. She also heads a number of multi-disciplinary projects with physicists and biophysicists to develop new methods to define spatio-temporal signalling events in living cells, tissues and organisms. As a result of her interest and applications of advanced microscopy, Maddy has developed strong working partnerships with a broad range of industrial collaborators, including Nikon, which led to the establishment of the state-of-the-art, world-class Nikon Imaging Centre at King’s College London of which she is Director. She also currently works alongside a number of other biotech and pharmaceutical companies to develop and apply advanced imaging approaches to understand basic mechanisms that underpin drug discovery and therapeutic development.
Read Maddy's article published in Biochemical Journal - Regulation of cell migration by α4 and α9 integrins.
Of winning the Industry and Academic Collaboration Award, Maddy said: “I am absolutely delighted to receive the 2019 Biochemical Society Industry and Academic Collaboration Award. I am really passionate about Interdisciplinary collaboration, which makes this honour particularly special for me. This award is really shared with all the highly talented and innovative academic and industrial collaborators that I have been privileged enough to work with”.
Maddy presented her award lecture at the Biochemical Society conference ‘Cell Signaling and Intracellular Trafficking in Cancer Biology: Interplay, Targeting and Therapy‘ on 21-24 October 2019 in Turin, Italy.
The inaugural Industry and Academic Collaboration Award was awarded in 2018 to Stefan Knapp from the Institute of Pharmaceutical Chemistry, the Buchmann Institute for Molecular Life Sciences at Frankfurt University as well as at the Structural Genomics Consortium at Oxford University. His research team made a major contribution to the understanding of structural mechanisms regulating signalling molecules such as protein kinases, phosphatases, acetylation dependent reader domains of the bromodomain family and the exploitation of this knowledge for the development of highly specific inhibitors. In the framework of a large collaborative network involving many academic research groups and industry he pioneered the development of protein interaction inhibitors targeting bromodomains that function as lysine acetylation dependent reader domains of the epigenetic code as well as highly specific allosteric inhibitors modulating kinase function.
Of winning the Industry and Academic Collaboration Award, Stefan said “I am extremely honoured and delighted to receive the 2018 Biochemical Society Industry and Academic Collaboration Award. I would like to use this opportunity to thank the outstanding team of scientists in academia and industry that I had the privilege collaborating with.”
Stefan presented his award lecture on 10 December 2018 at the University of Sussex.
Read Stefan's article published in the Biochemical Journal - Lessons from LIMK1 enzymology and their impact on inhibitor design